Cargando…

Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer

The effect on the IGF system of 60 mg and 600 mg daily of raloxifene administered for 2 weeks prior to surgery was investigated in 37 postmenopausal women with breast cancer. Raloxifene significantly decreased insulin-like growth factor (IGF-I) as compared to placebo (P < 0.05) with no dose–respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torrisi, R, Baglietto, L, Johansson, H, Veronesi, G, Bonanni, B, Guerrieri-Gonzaga, A, Ballardini, B, Decensi, A
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364027/ https://www.ncbi.nlm.nih.gov/pubmed/11747323 http://dx.doi.org/10.1054/bjoc.2001.2191

Ejemplares similares

Effect of Raloxifene Treatment on Osteocyte Apoptosis in Postmenopausal Women
por: van Essen, Huib W., et al.
Publicado: (2007)

A randomized phase II presurgical trial of weekly low-dose tamoxifen versus raloxifene versus placebo in premenopausal women with estrogen receptor-positive breast cancer
por: Serrano, Davide, et al.
Publicado: (2013)

Evaluation of insulin-like growth factor-I in postmenopausal women with breast cancer treated with raloxifene
por: da Silva, Benedito B, et al.
Publicado: (2007)

IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai
por: Probst-Hensch, N M, et al.
Publicado: (2001)

Cost-effectiveness of bazedoxifene versus raloxifene in the treatment of postmenopausal women in Spain
por: Darbà, Josep, et al.
Publicado: (2013)

Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020)

Chemoprevention studies within lung cancer screening programmes
por: Veronesi, G, et al.
Publicado: (2015)

Effects of minodronate in postmenopausal women with osteoporosis who received prior treatment with raloxifene
por: Toda, Aska, et al.
Publicado: (2017)

Effect of follow-up raloxifene therapy after denosumab discontinuation in postmenopausal women
por: Ha, J., et al.
Publicado: (2022)

Quality of life and patient satisfaction with raloxifene/cholecalciferol combination therapy in postmenopausal women
por: Lee, Dong-Yun, et al.
Publicado: (2022)

Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
por: Fujiwara, Saeko, et al.
Publicado: (2014)

Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm children
por: Kistner, Anna, et al.
Publicado: (2014)

The associations of anthropometric, behavioural and sociodemographic factors with circulating concentrations of IGF‐I, IGF‐II, IGFBP‐1, IGFBP‐2 and IGFBP‐3 in a pooled analysis of 16,024 men from 22 studies
por: Watts, Eleanor L., et al.
Publicado: (2019)

The effect of raloxifene on left ventricular hypertrophy in postmenopausal women: A prospective, randomized, and controlled study
por: Bal, Uğur Abbas, et al.
Publicado: (2015)

Changes in insulin resistance indicators, IGFs, and adipokines in a year-long trial of aerobic exercise in postmenopausal women
por: Friedenreich, Christine M, et al.
Publicado: (2011)

Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs
por: Song, Doo-Won, et al.
Publicado: (2021)

The effect of transdermal estradiol or oral conjugated oestrogen and fenretinide versus placebo on haemostasis and cardiovascular risk biomarkers in a randomized breast cancer chemoprevention trial
por: Lazzeroni, M, et al.
Publicado: (2008)

Comparative evaluation of raloxifene versus estrogen: Progestin on symptomatology, endometrium, and lipid profile in postmenopausal women
por: Dogiparthi, Anuradha, et al.
Publicado: (2010)

Cost-effectiveness of raloxifene in the treatment of osteoporosis in Chinese postmenopausal women: impact of medication persistence and adherence
por: Chen, Mingsheng, et al.
Publicado: (2016)

IGF-1 and IGFBP-3 in Inflammatory Cachexia
por: Martín, Ana Isabel, et al.
Publicado: (2021)

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition
por: Rohrmann, S, et al.
Publicado: (2012)

Investigating the Relationship Between IGF-I, IGF-II, and IGFBP-3 Concentrations and Later-Life Cognition and Brain Volume
por: Salzmann, Antoine, et al.
Publicado: (2021)

Genetic Polymorphisms in IGF-I and IGFBP-3 Are Associated with Prostate Cancer in the Chinese Population
por: Qian, Jian, et al.
Publicado: (2014)

Long-term safety and efficacy of raloxifene in the prevention and treatment of postmenopausal osteoporosis: an update
por: Messalli, Enrico M, et al.
Publicado: (2010)

Raloxifene/Vitamin D Combination Therapy vs. Raloxifene Monotherapy on Serum 25-Hydroxy-Vitamin D Level among Postmenopausal Women with Osteoporosis or Osteopenia: A Randomized Controlled Trial
por: Lee, You-Bin, et al.
Publicado: (2022)

Alendronate versus Raloxifene for Postmenopausal Women: A Meta-Analysis of Seven Head-to-Head Randomized Controlled Trials
por: Lin, Tiao, et al.
Publicado: (2014)

Effects of human insulin and insulin aspart preparations on levels of IGF-I, IGFBPs and IGF bioactivity in patients with type 1 diabetes
por: Ma, Zhulin, et al.
Publicado: (2014)

Correlation between Salivary Levels of IGF-1, IGFBP-3, IGF-1/IGFBP3 Ratio with Skeletal Maturity Using Hand-Wrist Radiographs
por: Almalki, Abdullah, et al.
Publicado: (2022)

A Novel Automated Immunoassay Platform to Evaluate the Association of Adiponectin and Leptin Levels with Breast Cancer Risk
por: Macis, Debora, et al.
Publicado: (2021)

Effect of i.p. insulin administration on IGF1 and IGFBP1 in type 1 diabetes
por: van Dijk, P R, et al.
Publicado: (2014)

IGF-I and IGFBP-3 before and after inpatient alcohol detoxification in alcohol-dependent subjects
por: Ilias, Ioannis, et al.
Publicado: (2011)

IGF-I and IGFBP-1 in Relation to Body Composition and Physical Performance in Female Olympic Athletes
por: Eklund, Emma, et al.
Publicado: (2021)

Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women
por: Marttunen, M B, et al.
Publicado: (2001)

Modeling the Annual Costs of Postmenopausal Prevention Therapy: Raloxifene, Alendronate, or Estrogen-Progestin Therapy
por: Mullins, C. Daniel, et al.
Publicado: (2003)

Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: a hospital-based analysis
por: Su, Fu-Mei, et al.
Publicado: (2015)

Optimism predicts sustained vigorous physical activity in postmenopausal women()
por: Progovac, Ana M., et al.
Publicado: (2017)

Role of Tumor and Stroma-Derived IGF/IGFBPs in Pancreatic Cancer
por: Thomas, Divya, et al.
Publicado: (2020)

IGFBP6 controls the expansion of chemoresistant glioblastoma through paracrine IGF2/IGF-1R signaling
por: Oliva, Claudia R., et al.
Publicado: (2018)

Serum insulin-like growth factors (IGFs) and IGF binding protein (IGFBP)-3 in patients with gastric cancer: IGFBP-3 protease activity induced by surgery.
por: Lee, D. Y., et al.
Publicado: (1997)

Raloxifene for older women: a review of the literature
por: Hansdóttir, Helga
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_eu3mrett6rcdqo1s9g4pf2e344